MedTrace Logo

Selective Ultrasound Screening for DDH 1991-2006

NCT01866527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81564

Last updated 2013-05-31

No results posted yet for this study

Summary

Early treatment is considered essential for developmental dysplasia of the hip (DDH), but the choice of screening strategy is debated. The investigators evaluated the effect of a selective ultrasound (US) screening programme.

All infants born in a defined region during 1991-2006 with increased risk of DDH, i.e. clinical hip instability, breech presentation, congenital foot deformities or a family history of DDH, were subjected to US screening at age one to three days. Severe sonographic dysplasia and/or dislocatable/dislocated hips were treated with abduction splints. Mild dysplasia and/or pathological instability, i.e. not dislocatable/dislocated hips were followed clinically and sonographically until spontaneous resolution, or until treatment became necessary. The minimum observation period was 5,5 years.

Conditions

  • Developmental Dysplasia of the Hip

Sponsors & Collaborators

  • Helse Vest

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Karen Rosendahl, PhD · Paediatric Section, Department of Radiology, Haukeland University hospital, Bergen

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1991-01-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01866527 on ClinicalTrials.gov